xabarchixabarchiABARCHI
Economics

Ozempic-maker accuses rival of false advertising

Novo Nordisk has launched legal action accusing Eli Lilly of creating "misleading" ads, a claim its rival denies.

Novo Nordisk, the pharmaceutical company behind Wegovy and Ozempic, has initiated legal action, accusing its main competitor, Eli Lilly, of false advertising. The lawsuit claims Eli Lilly's promotional

pharmaceutical lawsuitfalse advertisingweight-loss drugsnovo nordiskeli lillymounjaroozempicdrug market competition

Cookies on xabarchi

We use cookies to remember your language and theme. With your permission we also measure how the site is read: Microsoft Clarity, which records page views and on-page interactions, and our own count of returning readers. Nothing is measured until you accept.